Delivery Order SPE2DE24DA017-SPE2D625F171A

Award Date 10/28/24
Potential Completion Date 10/31/24
Potential Value $3.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,081.60 fixed-price contract, with economic price adjustment, is for the Arthrex ACP Double Syringe System. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $471,048,172.66 that Arthrex holds with the Department of Veterans Affairs (VA) to provide a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Arthrex Inc., a for-profit Subchapter S Corporation that specializes in minimally invasive orthopedic products and procedures. The contract, valued at $2,752.00, is for the supply of the Arthrex ACP Double Syringe System, a medical device used in orthopedic procedures. The contract has a period of performance from July 29, 2024, to August 1, 2024, and is a...
This is a delivery order award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the procurement of the Arthrex ACP Double Syringe System. The award, valued at $2,160.00, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract type is Fixed Price with Economic Price Adjustment, and the period of performance extends through November 14, 2022. This delivery order is placed under Arthrex's Indefinite Delivery...
This federal contract was awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $3,300.00 fixed-price delivery order contract is for the Arthrex ACP Double Syringe System and has an ultimate completion date of May 27, 2025. The contract is not set aside for a specific business type. Arthrex Inc., a for-profit Subchapter S Corporation, has demonstrated its capability to provide a wide range of...
This is a $1,650.00 fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the Arthrex ACP Double Syringe System and has an ultimate completion date of March 4, 2025. Arthrex holds a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as SPE2DE24D0020, valued at $471,048,172.66 and running from June...
The U.S. government agency, the Defense Logistics Agency's Medical Supply Chain, awarded a Fixed Price with Economic Price Adjustment delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $2,475.00, is for the provision of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device. This award is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,939.62 fixed-price delivery order is for the Arthrex ACP Double Syringe System, which will be delivered by November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with the DLA that allows...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of 4,563,952,010 ARTHREX ACP DOUBLE SYRINGE SYSTEM, with a ceiling value of $11,556.00. The contract type is fixed-price with economic price adjustment, and the ultimate completion date is March 18, 2024. This delivery order is not associated with a set-aside...
This federal contract award is for the delivery of Arthrex ACP Double Syringe Systems to the Medical Supply Chain of the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $16,500.00 and is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. The ultimate completion date is December 5, 2024. The prime contractor is Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples,...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of an Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a fixed price with economic price adjustment, a ceiling value of $3,300.00, and runs through November 15, 2024. This order is part of a larger Indefinite Delivery...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F171A
    Delivery Order

This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,438.65 fixed-price contract, with economic price adjustment, is for the supply of the Arthrex ACP Double Syringe System. This product is used in orthopedic procedures and is being provided to support the medical needs of the Department of Defense and Department of Veterans Affairs healthcare systems. The contract does not have a set-aside designation, indicating Arthrex's competitive position in the federal market. Arthrex also holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the DLA, which allows VA medical centers nationwide to acquire a wide range of Arthrex's innovative orthopedic technologies through task orders.

Generated 2/2/25, 12:07 AM